Sanofi (SNYNF, SNY) said the EU has approved Sarclisa in combination with a standard-of-care regimen, bortezomib, lenalidomide, and ...
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...
Sanofi (SNYNF – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from Bank ...
Herbal Medicinal Products market Insights: Growing consumer preference for natural and organic products drives market expansion.
L’Etat avait une part de responsabilité dans l’« insuffisance d’information » donnée aux patients et aux médecins sur les ...
Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...
SP-0230 is under clinical development by Sanofi and currently in Phase II for Neisseria meningitidis Infections.
PARIS _ Lors des JHTA, le Dr François Diévart a fait le point sur la place actuelle des bêta-bloquants. Ils ne sont plus, certes, des médicaments à prescrire d’emblée chez les hypertendus, mais ils ...
Votre e-mail, avec votre consentement, est utilisé par Ouest-France pour recevoir notre newsletter. En savoir plus. 20 septembre 2024, 29 novembre, 22 décembre. En trois mois, trois scènes de ...
Copyright 2025 The Associated Press. All Rights Reserved. French centrist presidential election candidate Emmanuel Macron, left, waves supporters as French centrist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback